Inogen, Inc. (INGN) |
| 5.5 -0.01 (-0.18%) 08-28 16:00 |
| Open: | 5.53 |
| High: | 5.68 |
| Low: | 5.45 |
| Volume: | 199,776 |
| Market Cap: | 149(M) |
| PE Ratio: | -6.04 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 6.93 |
| Resistance 1: | 6.36 |
| Pivot price: | 5.67 |
| Support 1: | 5.45 |
| Support 2: | 4.53 |
| 52w High: | 9.13 |
| 52w Low: | 5.34 |
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
| EPS | -0.910 |
| Book Value | 6.540 |
| PEG Ratio | 0.00 |
| Gross Profit | 5.942 |
| Profit Margin (%) | -6.94 |
| Operating Margin (%) | -5.13 |
| Return on Assets (ttm) | -5.8 |
| Return on Equity (ttm) | -13.1 |
Mon, 24 Aug 2026
Inogen (INGN) Results Versus Estimates: The Bottom-Line Figure Beats Its Comparison in the Latest Reading; Share Response: The Share Price Sheds 1.96% in the Available Record - Return On Equity - vinanet.vn
Fri, 21 Aug 2026
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - TradingView
Fri, 14 Aug 2026
Inogen (INGN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Tue, 11 Aug 2026
Should Investors Buy Inogen as Low Valuation Meets Execution Risk? - Yahoo Finance
Mon, 10 Aug 2026
Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut - TradingView
Sun, 09 Aug 2026
Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$12.67 - simplywall.st
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |